The International Pharmacopoeia

From Wikipedia, the free encyclopedia
Jump to: navigation, search

The International Pharmacopoeia (Pharmacopoeia Internationalis, Ph. Int.) is a pharmacopoeia issued by the World Health Organization[1] as a recommendation, with the aim to achieve a wide global uniformity of quality specifications for selected pharmaceutical drugs, excipients, and dosage forms.

The information published in the International Pharmacopoeia is collated via a consultative procedure and is based on international experience, the monographs being established in an independent manner.

Priority is given to medicines that are widely used throughout the world. High priority is accorded to medicines that are important to WHO health programs, and which may not appear in any other pharmacopoeias, e.g., new antimalarial drugs.

List of the editions of international pharmacopoeia[edit]

Sort Edition number Year Medium Notes
1 First Edition 1951 (Volume 1)[2]
1955 (Volume 2)[2]
Print 2 volumes plus supplement[2]
2 Second Edition 1967[2] Print
3 Third Edition 1979[2] Print 5 volumes[2]
4 Fourth Edition 2006[2] Print or CD-ROM[2] 2 volumes[2]
5 Fifth Edition 2015[1] online[1]
6 Sixth Edition 2016[1] online[1]

See also[edit]


  1. ^ a b c d e WHO (2015), The International Pharmacopoeia (5th ed.). 
  2. ^ a b c d e f g h i World Health Organization (2006), The International Pharmacopoeia (4th ed.), World Health Organization, ISBN 924156301X. 

External links[edit]

Official website